Publication:
Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans

cris.lastimport.scopus2025-05-09T22:15:21Z
cris.virtual.departmentImmunologyen_US
cris.virtual.orcid0000-0001-6891-6945en_US
cris.virtualsource.department74afae9e-7702-4e64-a5e7-34f4afa685fe
cris.virtualsource.orcid74afae9e-7702-4e64-a5e7-34f4afa685fe
dc.contributor.authorRijal P.en-US
dc.contributor.authorElias S.C.en-US
dc.contributor.authorMachado S.R.en-US
dc.contributor.authorXiao J.en-US
dc.contributor.authorSchimanski L.en-US
dc.contributor.authorO'Dowd V.en-US
dc.contributor.authorBaker T.en-US
dc.contributor.authorBarry E.en-US
dc.contributor.authorMendelsohn S.C.en-US
dc.contributor.authorCherry C.J.en-US
dc.contributor.authorJin J.en-US
dc.contributor.authorLabb? G.M.en-US
dc.contributor.authorDonnellan F.R.en-US
dc.contributor.authorRampling T.en-US
dc.contributor.authorDowall S.en-US
dc.contributor.authorRayner E.en-US
dc.contributor.authorFindlay-Wilson S.en-US
dc.contributor.authorCarroll M.en-US
dc.contributor.authorGuo J.en-US
dc.contributor.authorXu X.-N.en-US
dc.date.accessioned2023-01-11T07:22:37Z
dc.date.available2023-01-11T07:22:37Z
dc.date.issued2019
dc.identifier.doi10.1016/j.celrep.2019.03.020
dc.identifier.issn2211-1247
dc.identifier.pmid30943399
dc.identifier.scopus2-s2.0-85063199073
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85063199073&doi=10.1016%2fj.celrep.2019.03.020&partnerID=40&md5=b3663ba95440edddf97dad3ecb4ed0fb
dc.identifier.urihttps://scholars.lib.ntu.edu.tw/handle/123456789/627152
dc.publisherElsevier B.V.
dc.relation.ispartofCell Reports
dc.relation.journalissue1
dc.relation.journalvolume27
dc.relation.pages172-1860000000
dc.subject.classification[SDGs]SDG3
dc.titleTherapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humansen_US
dc.typejournal articleen
dspace.entity.typePublication

Files